Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Eur Acad Dermatol Venereol ; 36(9): 1606-1611, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35543077

ABSTRACT

BACKGROUND: Pathogenic variants in KITLG, a crucial protein involved in pigmentation and neural crest cell migration, cause non-syndromic hearing loss, Waardenburg syndrome type 2, familial progressive hyperpigmentation and familial progressive hyper- and hypopigmentation, all of which are inherited in an autosomal dominant manner. OBJECTIVES: To describe the genotypic and clinical spectrum of biallelic KITLG-variants. METHODS: We used a genotype-first approach through the GeneMatcher data sharing platform to collect individuals with biallelic KITLG variants and reviewed the literature for overlapping reports. RESULTS: We describe the first case series with biallelic KITLG variants; we expand the known hypomelanosis spectrum to include a 'sock-and-glove-like', symmetric distribution, progressive repigmentation and generalized hypomelanosis. We speculate that KITLG biallelic loss-of-function variants cause generalized hypomelanosis, whilst variants with residual function lead to a variable auditory-pigmentary disorder mostly reminiscent of Waardenburg syndrome type 2 or piebaldism. CONCLUSIONS: We provide consolidating evidence that biallelic KITLG variants cause a distinct auditory-pigmentary disorder. We evidence a significant clinical variability, similar to the one previously observed in KIT-related piebaldism.


Subject(s)
Hearing Loss, Sensorineural , Hyperpigmentation , Hypopigmentation , Piebaldism , Hearing Loss, Sensorineural/genetics , Humans , Hypopigmentation/genetics , Stem Cell Factor , Waardenburg Syndrome
2.
J Laryngol Otol ; 132(8): 718-723, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29998809

ABSTRACT

OBJECTIVE: This prospective, controlled study assessed how placing a stent into a newly formed ostium affects ostial patency, success and complication rates in endoscopic dacryocystorhinostomy patients. METHODS: In group 1 (40 eyes of 36 patients), both silicone tube intubation and tube stenting were performed. In group 2 (36 eyes of 34 patients), only silicone tube intubation was performed. Success, operative time and post-surgical complications were investigated two months post-operatively in each group. RESULTS: The success rates were 92.5 per cent and 83.3 per cent for groups 1 and 2 respectively, but the difference was not statistically significant (p = 0.294). The complication rates also differed between the two groups, but this was again insignificant. CONCLUSION: Compared with the use of a silicone tube alone, the addition of an ostial stent did not significantly increase the success rate of endoscopic dacryocystorhinostomy.


Subject(s)
Dacryocystitis/surgery , Dacryocystorhinostomy/instrumentation , Intubation/instrumentation , Natural Orifice Endoscopic Surgery/instrumentation , Stents , Adult , Aged , Aged, 80 and over , Dacryocystitis/complications , Dacryocystitis/diagnosis , Female , Humans , Male , Middle Aged , Operative Time , Treatment Outcome , Turkey
3.
Hum Exp Toxicol ; 36(7): 663-669, 2017 Jul.
Article in English | MEDLINE | ID: mdl-27461010

ABSTRACT

INTRODUCTION: Anthrax is a bacterial disease caused by the aerobic sporeforming bacterium Bacillus anthracis. It has been suggested that oxidative stress plays an important role in the pathogenesis of B. anthracis. The aim of this study was to investigate serum paraoxonase 1 (PON1) activity, catalase activity, malondialdehyde (MDA) levels, and superoxide dismutase (SOD) levels in patients with cutaneous anthrax. MATERIALS AND METHODS: Fifteen patients with cutaneous anthrax and 15 healthy controls were enrolled in this study. The serum MDA levels, SOD levels, paraoxonase, arylesterase, and catalase activities were measured using a spectrophotometer. RESULTS: The serum SOD levels, paraoxonase, arylesterase, and catalase activities were significantly lower in patients with cutaneous anthrax than in controls (for all, p < 0.001), whereas MDA levels were significantly higher ( p < 0.001). No significant correlation was found between serum paraoxonase activity, arylesterase activity, SOD levels, and MDA levels (all, p > 0.05) in patients with cutaneous anthrax. CONCLUSIONS: The current study was the first to show decreased antioxidant levels and increased oxidant levels in patients with cutaneous anthrax. Therefore, decreased PON1 activity may play a role in the pathogenesis of cutaneous anthrax.


Subject(s)
Anthrax/blood , Aryldialkylphosphatase/blood , Oxidative Stress , Skin Diseases, Bacterial/blood , Adult , Carboxylic Ester Hydrolases/blood , Catalase/blood , Cholesterol/blood , Female , Humans , Male , Malondialdehyde/blood , Middle Aged , Superoxide Dismutase/blood , Triglycerides/blood
4.
Sci Rep ; 6: 31622, 2016 08 26.
Article in English | MEDLINE | ID: mdl-27562378

ABSTRACT

The genetics of both syndromic (SHL) and non-syndromic hearing loss (NSHL) is characterized by a high degree of genetic heterogeneity. We analyzed whole exome sequencing data of 102 unrelated probands with apparently NSHL without a causative variant in known NSHL genes. We detected five causative variants in different SHL genes (SOX10, MITF, PTPN11, CHD7, and KMT2D) in five (4.9%) probands. Clinical re-evaluation of these probands shows that some of them have subtle syndromic findings, while none of them meets clinical criteria for the diagnosis of the associated syndrome (Waardenburg (SOX10 and MITF), Kallmann (CHD7 and SOX10), Noonan/LEOPARD (PTPN11), CHARGE (CHD7), or Kabuki (KMT2D). This study demonstrates that individuals who are evaluated for NSHL can have pathogenic variants in SHL genes that are not usually considered for etiologic studies.


Subject(s)
Connexins/genetics , Deafness/genetics , Genetic Predisposition to Disease , Adolescent , Child , Child, Preschool , Cohort Studies , DNA Helicases/genetics , DNA-Binding Proteins/genetics , Exome , Female , Genetic Heterogeneity , Genetic Variation , Humans , Male , Microphthalmia-Associated Transcription Factor/genetics , Mutation , Neoplasm Proteins/genetics , Pedigree , Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics , SOXE Transcription Factors/genetics , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...